Amanda E. Toland
Affiliations: | Molecular Cellular and Developmental Biology | Ohio State University, Columbus, Columbus, OH |
Area:
Cell Biology, OncologyGoogle:
"Amanda Toland"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Barnes DR, Tyrer JP, Dennis J, et al. (2024) Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk. Medrxiv : the Preprint Server For Health Sciences |
| Levi H, Carmi S, Rosset S, et al. (2023) Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. Journal of Medical Genetics |
| Stolarova L, Kleiblova P, Zemankova P, et al. (2023) ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. OF1-OF14 |
| Mueller SH, Lai AG, Valkovskaya M, et al. (2023) Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. Genome Medicine. 15: 7 |
| Li H, Engel C, Hoya M, et al. (2022) Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 24: 2208 |
| Hakkaart C, Pearson JF, Marquart L, et al. (2022) Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers. Communications Biology. 5: 1061 |
| Barfield R, Qu C, Steinfelder RS, et al. (2022) Association between germline variants and somatic mutations in colorectal cancer. Scientific Reports. 12: 10207 |
| Georgeson P, Harrison TA, Pope BJ, et al. (2022) Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures. Nature Communications. 13: 3254 |
| Li S, Silvestri V, Leslie G, et al. (2022) Cancer Risks Associated With and Pathogenic Variants. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102112 |
| Li H, Engel C, de la Hoya M, et al. (2021) Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. Genetics in Medicine : Official Journal of the American College of Medical Genetics |